TP53 and familial pancreatic carcinoma: The most differentially over-represented signaling pathways in LUAD patients with the elevated MND1 expression included the p53 signaling pathway, pancreatic cancer, small cell lung cancer, bladder cancer, melanoma, and colorectal cancer (Table 5).